berotek and diazepam

berotek has been researched along with diazepam in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Campillo, NE; Guerra, A; Páez, JA1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Glen, RC; Lowe, R; Mitchell, JB1
Stünkel, S; Windorfer, A1
Pringsheim, W; Windorfer, A1
Rózewicki, S; Sienkiewicz, R1
Benesová, O; Dostál, M; Husek, P; Kristofiková, Z; Tejkalová, H1

Other Studies

10 other study(ies) available for berotek and diazepam

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
[Significance of pharmacogenic liver reactions for metabolism of endogenous and exogenous substances].
    Monatsschrift fur Kinderheilkunde, 1979, Volume: 127, Issue:3

    Topics: Carbamazepine; Diazepam; Drug-Related Side Effects and Adverse Reactions; Female; Fenoterol; Humans; Liver; Phenobarbital; Phenytoin; Pregnancy; Primidone

1979
[Investigation on the influence of a tocolytic treatment of pregnant women with diazepam and fenoterol on the bilirubin levels and apgar score of newborn (author's transl)].
    Klinische Padiatrie, 1979, Volume: 191, Issue:1

    Topics: Apgar Score; Bilirubin; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Female; Fenoterol; Humans; Infant, Newborn; Jaundice, Neonatal; Pregnancy; Retrospective Studies

1979
[Evaluation of combined application of diazepam, fenoterol and metamizole in prevention of uterine-tubal spasm during the performance of hysterosalpingography].
    Ginekologia polska, 1992, Volume: 63, Issue:10

    Topics: Diazepam; Dipyrone; Drug Therapy, Combination; Fallopian Tube Diseases; Fallopian Tube Patency Tests; Female; Fenoterol; Humans; Hysterosalpingography; Premedication; Spasm; Uterine Diseases

1992
[Perinatal pharmacotherapy and the risk of functional teratogenic defects].
    Ceskoslovenska fysiologie, 1995, Volume: 44, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Dexamethasone; Diazepam; Female; Fenoterol; Humans; Pregnancy; Pregnancy Complications; Risk Factors

1995